Related Announcements

RFA-AI-21-021 - Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community of the early expiration of Funding Opportunity Announcement (FOA) RFA-AI-21-021, "Enhancement or Sustainment of Data Science Tools for Infectious and Immune-Mediated diseases (U24 Clinical Trial Not Allowed)", effective immediately.

Applicants are encouraged to consider applying to the following FOAs:

RFA-AI-21-020 - Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed) for Research Project (Cooperative Agreements)

RFA-AI-21-035 - Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed) for Exploratory/Developmental Grants

Inquiries

Please direct all inquiries to:

Steve Tsang, PhD
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3330
Email: [email protected]